Published in Ann Surg on October 01, 1986
Liver transplantation (1). N Engl J Med (1989) 4.53
Significance of lecithin:cholesterol acyltransferase activity as a prognostic indicator of early allograft function in clinical liver transplantation. Transplantation (1989) 0.81
Pretransplant assessment of human liver grafts by plasma lecithin: cholesterol acyltransferase (LCAT) activity in multiple organ donors. Transpl Int (1992) 0.75
Evolution of liver transplantation. Hepatology (1982) 19.54
Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet (1979) 12.29
The disturbance of metabolism produced by bony and non-bony injury, with notes on certain abnormal conditions of bone. Biochem J (1930) 7.64
Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04
Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95
Orthotopic liver transplantation: a pathological study of 63 serial liver biopsies from 17 patients with special reference to the diagnostic features and natural history of rejection. Hepatology (1985) 2.18
Combined hormonal infusion simulates the metabolic response to injury. Ann Surg (1984) 1.97
Amino acid and energy metabolism in septic and traumatized patients. JPEN J Parenter Enteral Nutr (1980) 1.35
Biopsy findings in cases of rejection of liver allograft. J Clin Pathol (1985) 1.24
Biopsy-directed immunosuppression following hepatic transplantation in man. Transplantation (1985) 1.04
Metabolism during hepatic transplantation: indicators of allograft function. Surgery (1984) 1.02
Survival from sepsis. The significance of altered protein metabolism regulated by proteolysis inducing factor, the circulating cleavage product of interleukin-1. Ann Surg (1985) 1.00
Multiple systems organ failure: I. The basal state. J Trauma (1981) 0.99
Induction of hepatic protein synthesis by a peptide in blood plasma of patients with sepsis and trauma. Surgery (1984) 0.94
Prognosis and survival as determined by visceral amino acid clearance in severe trauma. J Trauma (1985) 0.90
The Boston Center for Liver Transplantation (BCLT). Initial experience of a new surgical consortium. Arch Surg (1986) 0.84
Liver transplantation. Surg Clin North Am (1985) 0.83
Amino acid clearance and prognosis in surgical patients with cirrhosis. Surgery (1984) 0.83
Incorporation rate of leucine into proteins in human liver slices. Eur J Clin Invest (1974) 0.80
Increased dependence of leucine in posttraumatic sepsis: leucine/tyrosine clearance ratio as an indicator of hepatic impairment in septic multiple organ failure syndrome. Surgery (1985) 0.79
Encephalopathy, oxygen consumption, visceral amino acid clearance, and mortality in cirrhotic surgical patients. Am J Surg (1984) 0.79
The case against conversion to azathioprine in cyclosporine-treated renal recipients. Transplant Proc (1985) 0.78
The management of fulminant hepatic failure. Prog Liver Dis (1970) 4.37
ACTION OF DINITRO COMPOUNDS ON SEA URCHIN EGGS. Science (1934) 3.71
ANTAGONISTIC ELECTROLYTE EFFECTS IN PHYSICAL AND BIOLOGICAL SYSTEMS. Science (1916) 3.66
Treatment of hepatic coma by exchange blood transfusion. N Engl J Med (1966) 2.69
Muscle proteolysis induced by a circulating peptide in patients with sepsis or trauma. N Engl J Med (1983) 2.49
Enterocolitis after the surgical treatment of Hirschsprung's disease: risk factors and financial impact. J Pediatr Surg (1998) 2.42
Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival. Cancer (1996) 2.26
Technical and biological factors in disease-free survival after hepatic resection for colorectal cancer metastases. Arch Surg (1992) 2.10
Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome. Ann Surg (1998) 2.10
Fulminant hepatic failure. Presumable contribution to halothane. N Engl J Med (1968) 1.99
Circulatory and metabolic alterations associated with survival or death in peritonitis: clinical analysis of 25 cases. Ann Surg (1966) 1.97
Appendectomy: a contemporary appraisal. Ann Surg (1997) 1.81
Aggressive surgical resection for cholangiocarcinoma. Arch Surg (1995) 1.80
Severity of liver injury in experimental alcoholic liver disease. Correlation with plasma endotoxin, prostaglandin E2, leukotriene B4, and thromboxane B2. Am J Pathol (1993) 1.75
Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver (disease). Proc Soc Exp Biol Med (1994) 1.71
Regulation of survivin expression by IGF-1/mTOR signaling. Oncogene (2006) 1.59
Snow-related recreational injuries in children: assessment of morbidity and management strategies. J Pediatr Surg (1999) 1.59
Heat stroke. N Engl J Med (1974) 1.54
THE SURFACE TREATMENT OF BURNS : A COMPARISON OF RESULTS OF TANNIC ACID, SILVER NITRATE, TRIPLE DYE, AND VASELINE OR BORIC OINTMENT AS SURFACE TREATMENTS IN 150 CASES. Ann Surg (1943) 1.51
Immunologic and metabolic effects of caval versus portal venous drainage in small-bowel transplantation. Surgery (1988) 1.50
Procurement of a whole pancreas and liver from the same cadaveric donor. Surgery (1989) 1.49
Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients. Cancer (1999) 1.48
Surgical management of nonparasitic cystic liver disease. Am J Surg (1991) 1.45
Protein sparing therapy during periods of starvation with sepsis of trauma. Ann Surg (1973) 1.45
Cleavage of human interleukin 1: isolation of a peptide fragment from plasma of febrile humans and activated monocytes. J Immunol (1984) 1.44
Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel. Hepatology (2000) 1.44
Surgical treatment of biliary cystadenoma. A report of 15 cases. Arch Surg (1988) 1.43
Electrocardiographic guided placement of central venous catheters. Br J Surg (1989) 1.40
Terminal duct carcinoma. Recognition of a low-grade salivary adenocarcinoma. Arch Otolaryngol Head Neck Surg (1994) 1.39
Angiogenesis in colorectal tumors: microvessel quantitation in adenomas and carcinomas with clinicopathological correlations. Cancer Res (1995) 1.39
Resting energy expenditure in patients with end-stage liver disease and in normal population. JPEN J Parenter Enteral Nutr (1987) 1.38
Death and dollars: the cost of dying in the surgical intensive care unit. J Trauma (1996) 1.38
Amino acid and energy metabolism in septic and traumatized patients. JPEN J Parenter Enteral Nutr (1980) 1.35
Hepatic transplantation survival: correlation with adenine nucleotide level in donor liver. Hepatology (1988) 1.32
Peripheral intravenous feeding with isotonic amino acid solutions. Am J Surg (1973) 1.32
Biliary carcinoma. A review of 109 cases. Am J Surg (1984) 1.30
The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt. Hepatology (1997) 1.29
Energy metabolism in sepsis: treatment based on different patterns in shock and high output stage. Ann Surg (1974) 1.28
Occult axillary lymph node metastases in "node-negative" breast carcinoma. Hum Pathol (1993) 1.25
Differential expression of microRNAs in human parathyroid carcinomas compared with normal parathyroid tissue. Endocr Relat Cancer (2010) 1.25
Distal splenorenal shunt vs. portal-systemic shunt: current status of a controlled trial. Hepatology (1981) 1.24
Energy metabolism and proteolysis in traumatized and septic man. Surg Clin North Am (1976) 1.24
Fibrinolysis during liver transplantation in humans: role of tissue-type plasminogen activator. Blood (1988) 1.22
The high-risk liver allograft recipient. Should allocation policy consider outcome? Arch Surg (1992) 1.22
Exchange of amino acids by muscle and liver in sepsis. Arch Surg (1983) 1.21
The uses of multiple causes of death data to clarify changing patterns of cirrhosis mortality in Massachusetts. Am J Public Health (1977) 1.21
Nodular lymphoid lesion of the liver: an immune-mediated disorder mimicking low-grade malignant lymphoma. Am J Surg Pathol (1999) 1.19
Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study. Ann Oncol (2006) 1.18
Diagnostic value of ascites adenosine deaminase in tuberculous peritonitis. Lancet (1989) 1.16
Primary mediastinal masses. A comparison of adult and pediatric populations. J Thorac Cardiovasc Surg (1993) 1.16
Septic lung and shock lung in man. Ann Surg (1975) 1.15
Cavernous hemangioma of the liver: anatomic resection vs. enucleation. Arch Surg (1999) 1.15
Nonoperative management of pancreatic injuries in children. J Pediatr Surg (1998) 1.14
The fulminant hepatic failure surveillance study. Brief review of the effects of presumed etiology and age of survival. Can Med Assoc J (1972) 1.13
Pathologic findings on re-excision of the primary site in breast cancer patients considered for treatment by primary radiation therapy. Cancer (1987) 1.13
Live donor adult liver transplantation using right lobe grafts: donor evaluation and surgical outcome. Arch Surg (2001) 1.13
Observations on the pathogenesis of the pneumonitis associated with severe infections in other parts of the body. Ann Surg (1968) 1.13
Liver transplantation for primary hepatic cancer. Transplantation (1992) 1.13
Detection of K-ras mutations in pancreatic and hepatic neoplasms by non-isotopic mismatched polymerase chain reaction. Oncogene (1991) 1.12
Occupational lead exposure, nephropathy, and renal cancer. Am J Ind Med (1980) 1.12
Circulating factors in the etiology of pulmonary insufficiency and right heart failure accompanying severe sepsis (peritonitis). Ann Surg (1970) 1.11
EGFR overexpression in malignant pleural mesothelioma. An immunohistochemical and molecular study with clinico-pathological correlations. Lung Cancer (2005) 1.11
Human monoclonal antibody MBL-HCV1 delays HCV viral rebound following liver transplantation: a randomized controlled study. Am J Transplant (2013) 1.11
p53 protein accumulation and p53 gene mutation in esophageal carcinoma. A molecular and immunohistochemical study with clinicopathologic correlations. Cancer (1997) 1.10
Medullary and papillary carcinoma of the thyroid gland occurring as a collision tumour: report of three cases with molecular analysis and review of the literature. Endocr Relat Cancer (2005) 1.10
Downregulation of p27KIP1 and Ki67/Mib1 labeling index support the classification of thyroid carcinoma into prognostically relevant categories. Am J Surg Pathol (1999) 1.10
Breast and ovarian metastatic localization of signet-ring cell gastric carcinoma. Ann Oncol (2003) 1.08
Psychiatric syndromes in children and their relation to family background. Am J Orthopsychiatry (1966) 1.08
A randomized clinical trial comparing OKT3 and steroids for treatment of hepatic allograft rejection. Transplantation (1987) 1.07
A rat fatty liver transplant model. Transplantation (1993) 1.07
Surgical therapy for recurrent liver metastases from colorectal cancer. Arch Surg (1990) 1.06
Steatosis in donor and transplant liver biopsies. Hum Pathol (2000) 1.06
Shifting proportions of gastric adenocarcinomas. Arch Surg (1994) 1.06
Proteolysis associated with a deficit of peripheral energy fuel substrates in septic man. Surgery (1976) 1.06
Down-regulation of beta 1C integrin, an inhibitor of cell proliferation, in prostate carcinoma. Am J Pathol (1996) 1.06
Blood insulin responses to blood glucose levels in high output sepsis and spetic shock. Am J Surg (1978) 1.06
Pericentral hepatic fibrosis and intracellular hyalin in diabetes mellitus. Gastroenterology (1980) 1.06
The direct-injection GLC analysis of xylenols in industrial wastewaters. Bull Environ Contam Toxicol (1977) 1.06
Improved survival after live donor adult liver transplantation (LDALT) using right lobe grafts: program experience and lessons learned. Am J Transplant (2006) 1.06
Risk factors for invasive fungal infections complicating orthotopic liver transplantation. J Infect Dis (1994) 1.05
Inflammatory myofibroblastic tumor of the pancreaticobiliary region: morphologic and immunocytochemical study of three cases. Am J Surg Pathol (1998) 1.04
Lymph node negative invasive breast carcinoma 1 centimeter or less in size (T1a,bNOMO): clinicopathologic features and outcome. Cancer (1997) 1.04
Gene expression analysis of early and advanced gastric cancers. Oncogene (2007) 1.03
A randomized clinical trial comparing OKT3 and steroids for treatment of hepatic allograft rejection. Transplant Proc (1987) 1.03
Beta1C integrin in epithelial cells correlates with a nonproliferative phenotype: forced expression of beta1C inhibits prostate epithelial cell proliferation. Am J Pathol (1998) 1.03
Retroversus implantation of a liver graft: a novel approach to the deceased donor with situs inversus totalis. Am J Transplant (2007) 1.03
Molecular alterations of Barrett's esophagus on microdissected endoscopic biopsies. Lab Invest (2001) 1.03
Widespread cytomegalovirus gastroenterocolitis in a patient with acquired immunodeficiency syndrome. Gastroenterology (1983) 1.02
The circulatory abnormalities of heat stroke. N Engl J Med (1972) 1.02
Allelic deletion and mutation of the von Hippel-Lindau (VHL) tumor suppressor gene in pancreatic microcystic adenomas. Am J Pathol (1997) 1.01
Role of staging laparoscopy in the treatment of hepatic malignancy. Am J Surg (1994) 1.01
High prevalence of testicular cancer in azoospermic men without spermatogenesis. Hum Reprod (2007) 1.01
Ganciclovir therapy of severe cytomegalovirus infections in solid-organ transplant recipients. Transplantation (1988) 1.01
Jejunoileal bypass for morbid obesity: early results and body composition changes in forty-five patients. Surgery (1976) 1.01
Survival from sepsis. The significance of altered protein metabolism regulated by proteolysis inducing factor, the circulating cleavage product of interleukin-1. Ann Surg (1985) 1.00
A phase II trial of 5-fluorouracil, leucovorin, and carboplatin in patients with unresectable biliary tree carcinoma. Cancer (1998) 1.00